Irradiation Apparatus Market Size, Share & Trends Analysis Report By Type (Gamma Rays, X-rays, Electrons), By Application (Diagnostic, Therapeutic, Dental), By End Use (Hospitals, Laboratories), By Region, And Segment Forecasts, 2025 - 2030

Irradiation Apparatus Market Size & Trends

The global irradiation apparatus market size was estimated at USD 7.89 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030.  The increasing demand for non-invasive medical procedures is a significant driving factor in the growth of the irradiation apparatus market. As patients and healthcare providers seek alternatives to traditional invasive methods, non-invasive procedures, which often require precise sterilization and equipment, are gaining popularity. Furthermore, the increased usage of irradiation devices in nuclear medicine for both diagnostic and therapeutic applications is further propelling market growth.

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases and musculoskeletal disorders, prostate cancer, breast cancer is a significant driver for the adoption of non-invasive diagnostic solutions. These conditions necessitate sophisticated imaging techniques, where the use of X-ray and other irradiation apparatus is widely used. Such devices enable early and accurate diagnosis, allowing for timely intervention and treatment that does not require invasive procedures. The number of cancer cases in U.S. reached 1.9 million in 2022 according to the American Cancer Society, lung cancer is one of the most diagnosed cancers, with over 234,580 new cases expected in U.S. in 2024 alone.

Furthermore, according to WHO, in 2022, approximately 20 million new cases of cancer were reported, resulting in 9.7 million deaths. An estimated 53.5 million individuals survived for at least 5 years after being diagnosed with cancer. Roughly one-fifth of the global population is affected by cancer during their lifetime, with around 1 in 9 men and 1 in 12 women succumbing to the illness. In addition, this number is projected to reach 24.5 million by 2030. In 2020, cancer accounted for an estimated 10 million deaths. Furthermore, according to WHO’s Cancer Facts, breast, lung, colorectum, prostate, skin, and stomach cancers are the topmost prevalent cancers globally.

The expanding scope of nuclear medicine has driven the demand for irradiation equipment that ensures high precision in medical imaging and treatment delivery. This trend underscores the critical role of irradiation apparatus in enhancing the capabilities of healthcare services globally The usage of hypo fractionated radiotherapy contributes to notable growth globally market for irradiation apparatus. This treatment method, which delivers higher doses of radiation over fewer sessions, improves patient adherence and treatment outcomes while reducing overall healthcare costs. This approach optimizes the use of current equipment, making existing radiotherapy systems more efficient. Furthermore, it fuels demand for advanced technologies such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT), which are essential for delivering precise and effective treatment. Consequently, these advancements and treatment innovations drive market growth for irradiation apparatus globally.

Furthermore, technological innovations in radiation therapies such as proton beam therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiotherapy, have enhanced cancer treatments. The trend helps to increase the dose of radiation to affected tumors and at the same time, reduce the effects on the healthy tissues. For instance, In June 2024, Thermo Fisher Scientific has launched the NetDose PRO radiation dosimeter, designed to enhance safety and accuracy in measuring radiation exposure. This device is accredited by the National Voluntary Laboratory Accreditation Program (NVLAP), ensuring it meets high safety standards. The NetDose PRO aims to improve radiation monitoring in various settings, including healthcare and research environments. The launch of Thermo Fisher Scientific's NetDose PRO radiation dosimeter highlights advancements in radiation safety technology, which is crucial for environments utilizing irradiation devices.

Moreover, proton beam therapy is considered a standard treatment for paranasal lesions, lesions at the base of the skull, and nasal lesions, as the dose to other critical organs surrounding the skull can be reduced with proton beam therapy. Protons, at a high energy level, can destroy cancer cells. Proton therapy allows targeted and precise delivery of dose as the large mass of protons does not allow them to scatter. ION Beam Applications (IBA) is the most prominent player in the proton therapy market.

Market Concentration & Characteristics

The irradiation apparatus industry is undergoing significant growth, driven by technological advancements coupled with heightened healthcare demands and changing patient expectations. Innovations in imaging modalities, intensity-modulated radiation therapy and advancements in e-beam technology have also focused on precision. The ability to control the dose of radiation precisely minimizes exposure to surrounding materials, thereby preserving the integrity of sensitive medical devices.

Prominent service providers in the irradiation apparatus industry are actively pursuing a range of strategic initiatives, such as product approval, upgrades, collaborations, and acquisitions, to sustain their competitive advantage and address the evolving demands of the market. For instance, in February 2024, Siemens Healthineers AG received U.S. FDA 510(k) clearance to TrueBeam and Edge radiotherapy systems advanced with HyperSight imaging solution. These devices help physicians plan and offer accurate treatment to patients for their cancer treatment.

The irradiation apparatus industry is witnessing continuous advancement by The irradiation apparatus industry is witnessing continuous advancements in imaging, cancer treatment, and further driven by increasing R&D investment and a focus on precision and safety. For instance, In March 2024, researchers at Fermilab have developed an electron beam accelerator to sterilize medical equipment, providing a faster, chemical-free alternative to traditional sterilization methods. This innovation uses electron beams to effectively eliminate harmful pathogens, offering a more efficient solution for the medical industry.

Iirradiation apparatus industry is witnessing a notable increase in partnerships and collaborations as companies strive to expand their service offerings and engage a broader customer base. These collaborations often involve sharing advanced technologies and expertise, significantly enhancing participating organizations' service capabilities. For instance, in October 2024, IBA (Ion Beam Applications S.A.) and Jubilant Radiopharma announced a significant partnership aimed at enhancing the production of positron emission tomography (PET) radiopharmaceuticals globally This collaboration involves the installation of five Cyclone KIUBE 180 cyclotrons at various Jubilant facilities, as part of a broader USD 50 million expansion plan for their PET manufacturing network.

The Irradiation apparatus market operates under stringent regulations aimed to ensure safety, quality, and compliance, with oversight from agencies like the FDA. These regulations shape product development and market entry, reinforcing public health standards. For instance, in March 2022, FDA granted 510(K) clearances to Radiaction Medical Ltd. for its Shield System, designed to enhance radiation protection in interventional cardiology and electrophysiology procedures.

The irradiation apparatus industry faces moderate competition from alternative imaging and diagnostic methods, such as ultrasound and MRI, but irradiation remains essential for applications requiring deep tissue penetration and precise treatment.

The Irradiation apparatus market is expanding regionally, with increased investment in key healthcare hubs. This growth is driven by technological demand and healthcare providers’ needs, particularly in cancer therapy and diagnostics. Recently, in September 2024, BGS Beta-Gamma-Service, a German sterilization company, is expanding its operations into the U.S. with a new facility in Pittsburgh, Pennsylvania, which is likely to focus on electron beam (e-beam) sterilization. This facility marks BGS's first location outside of Germany, where it currently operates three sterilization sites. The Pittsburgh facility is projected to become operational by mid-2025.

Type Insights

X-Rays segment held the largest market share of about 33.65% in 2024. The segment growth is driven by increasing healthcare demands, particularly for diagnostic imaging services due to the rising prevalence of chronic diseases such as cancer and cardiovascular conditions. The transition from traditional film-based X-rays to digital systems has significantly improved image quality, processing speed, and workflow efficiency, further contributing to market expansion. Beyond diagnostics, X-ray apparatus also play a role in radiation therapy, particularly for superficial tumors. Increasing adoption in both hospital and outpatient settings reflects its fundamental role in healthcare, as well as the rising prevalence of chronic diseases globally that necessitate regular monitoring.

Gamma rays segment is expected to grow at the fastest rate of 7.2% CAGR over the forecast period, owing to the factors such as gamma irradiation is cost-effective, safe, and is widely used in oncology for radiotherapy and in sterilizing medical devices. Increasing demand for minimally invasive cancer treatments and enhanced patient safety has fueled the adoption of gamma-ray-based equipment. It does not require heat, steam, or strict humidity, temperature, or pressure controls. The process also doesn't significantly increase the temperature of the products, making it ideal for heat sensitive devices. Advances in gamma ray technology, such as intensity-modulated radiation therapy (IMRT), have further optimized treatment effectiveness, particularly for complex cases. The adoption of such apparatus is supported by an increasing number of cancer patients and the need for accurate imaging solutions.

Application Insights

Diagnostics segment held the largest market share of about 41.31% in 2024. The demand for non-invasive diagnostics drives innovation in this segment, with developments focusing on faster imaging times and advanced features, such as 3D imaging and dose reduction technologies, for more precise diagnostics. As digital imaging technology advances, diagnostic irradiation apparatus are increasingly capable of providing detailed images with lower radiation exposure. This enhances patient safety while supporting early disease detection, which aligns with the healthcare focus on preventive care.

Therapeutic segment is expected to grow at the fastest rate of 6.6% CAGR over the forecast period. It is vital in treating various cancers and other serious conditions, leveraging radiation's ability to target and destroy abnormal cells. Technologies such as linear accelerators, gamma knives, and proton therapy systems are central to radiotherapy, Furthermore, few more recent developments includes Particle Beam Therapy (PBT), advanced forms of radiation therapy provide precise targeting of tumors while minimizing damage to surrounding healthy tissues. Several new proton therapy centers have been established across the world, driven by increasing investment and the potential for reduced side effects in cancer patients.

End Use Insights

Hospitals segment held the largest market share of about 44.7% in 2024, as hospitals are investing heavily in upgrading their medical imaging capabilities to enhance patient outcomes and operational efficiency, thereby driving growth in this segment. In addition to diagnostic equipment, therapeutic applications such as radiotherapy are critical components of hospital operations. The integration of advanced irradiation technologies, including proton beam therapy and digital imaging systems, is reshaping treatment protocols and improving patient care standards. Hospitals are increasingly adopting these technologies not only for their effectiveness but also for their ability to minimize radiation exposure while maximizing therapeutic benefits.

The laboratories segment is anticipated to experience the fastest growth over the forecast period. Laboratories play a pivotal role in advancing nuclear medicine applications, where irradiation devices are employed for both diagnostic imaging and therapeutic interventions. The integration of these technologies into laboratory practices not only improves diagnostic accuracy but also supports innovative treatment methodologies for diseases such as cancer. As laboratories continue to adopt cutting-edge irradiation technologies, they contribute significantly to the overall growth of the market.

Regional Insights

North America dominated the irradiation apparatus market with a share of 43.68% in 2024, owing to advanced healthcare infrastructure and significant investments in R&D. Key drivers include the high prevalence of neurological disorders and growing adoption of innovative technologies. Leading players are focusing on product launches and strategic collaborations, creating growth opportunities.

U.S. Irradiation Apparatus Market Trends

The irradiation apparatus market in U.S. held a significant share of market in 2024, Owing to robust healthcare spending, rising demand for minimally invasive therapies, and a strong presence of market leaders driving innovation. Moreover, the presence of key players, such as Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Nordion, Inc., is anticipated to positively impact market growth by taking various strategic steps, such as partnerships & collaborations, to expand business or portfolio. For instance, in February 2024, the U.S. FDA granted 510(k) clearance to Siemens Healthineers AG’s TrueBeam and Edge radiotherapy systems advanced with HyperSight imaging solution. These devices help physicians plan and offer accurate treatment to patients for their cancer treatment.

The irradiation apparatus market in Canada held a significant share of market in 2024. This growth is attributed to increased government initiatives to enhance diagnostic imaging facilities, a growing focus on radiation safety, and expanding applications in oncology. The country also benefits from collaborations between research institutions and irradiation apparatus manufacturers.

Europe Irradiation Apparatus Market Trends

The irradiation apparatus market in Europe is experiencing significant growth. Europe held the second-largest market share and is anticipated to grow at a significant rate over the forecast period. Europe is one of the most advanced regions globally with advanced technologies and infrastructure, resulting in significant healthcare facilities and high-quality patient care.

The irradiation apparatus market in UK is likely to show significant growth. Its driven by advancements in healthcare infrastructure and a rising prevalence of chronic diseases requiring radiation-based therapies.

Asia Pacific Irradiation Apparatus Market Trends

The irradiation apparatus market in Asia Pacific is experiencing rapid growth due to rising awareness of radiation-based diagnostics, and favorable government policies further propel growth in this region, further the presence of several local players in China and Japan is expected to boost the market growth. The adoption of radiation therapy is notably rising in Asia Pacific's developing countries, as seen in India, which boasts around 545 teletherapy machines. Even smaller countries like Bangladesh have made significant strides in acquiring advanced radiotherapy equipment, including linear accelerators, Cobalt 60 machines, and HDR units across multiple centers.

The irradiation apparatus market in China is growing with a lucrative growth rate. China is witnessing a particularly high growth rate, supported by technological advancements and expanding healthcare infrastructure. Furthermore, China's irradiation apparatus market accounted for a significant share of APAC owing to various factors such as the introduction of new technologies and a large target population. In addition, the rising number of collaborations and partnerships among organizations is expected to drive the radiation oncology market in this country.

Latin America Irradiation Apparatus Market Trends

The irradiation apparatus market in Latin America is experiencing significant growth, driven by the expansion of healthcare systems and increasing access to advanced medical devices. Countries like Brazil and Mexico are investing heavily in diagnostic imaging and radiation therapy equipment. The region also benefits from rising awareness of early cancer diagnosis, fueling demand for irradiation apparatus.

Middle East and Africa Irradiation Apparatus Market Trends

The irradiation apparatus market in MEA is experiencing growth driven by the MEA accounted for a considerable market share in 2024, driven by rising healthcare investments and improving access to advanced medical technologies. Saudi Arabia, in particular, is leading the market with significant government initiatives to modernize healthcare infrastructure and adopt advanced radiation therapy equipment. The growing focus on medical tourism in the region further contributes to market expansion.

The irradiation apparatus market in Saudi Arabia is driven by increasing investments in healthcare infrastructure and government initiatives to modernize medical facilities under programs like Saudi Vision 2030. The rising prevalence of cancer and other chronic diseases has amplified the demand for advanced diagnostic imaging and radiation therapy equipment. In addition, a growing focus on medical tourism and the adoption of cutting-edge irradiation technologies in hospitals and clinics further fuel market growth in the country.

Key Irradiation Apparatus Company Insights

Major players in the irradiation apparatus industry are actively enhancing their product offerings to capture a larger market share and expand their customer base. These companies are investing in the latest technological upgrades to improve the quality and efficiency of their irradiation apparatus. Moreover, they are pursuing strategic acquisitions to broaden their service portfolios and enter new geographic regions, thereby strengthening their market position. In addition, partnerships with other healthcare providers and technology firms are being formed to leverage complementary strengths and integrate innovative solutions. Securing government clearances and regulatory approvals also remains a critical focus for these organizations.

Recent Developments

• In October 2024, Precision X-Ray partnered with Gilardoni SpA to distribute the RADGIL2 X-ray blood irradiator globally. This device provides a safe and efficient method for blood irradiation, crucial in preventing transfusion-related diseases like Transfusion-associated Graft versus Host Disease (TA-GvHD).

• In August 2024, Sterigenics International, a global leader in contract sterilization and laboratory services acquired Nordion. This strategic acquisition aims to strengthen Nordion’s position in the sterilization industry, particularly in gamma irradiation.

• In April 2024, GE Healthcare partnered with Elekta and MIM Software to enhance radiation therapy solutions. In its collaboration with Elekta, GE aims to improve cancer care by integrating imaging and radiation therapy technology, streamlining workflows, and enhancing treatment precision for oncology professionals.

• In February 2024, the U.S. FDA granted 510(k) clearance to Siemens Healthineers AG’s TrueBeam and Edge radiotherapy systems advanced with HyperSight imaging solution. These devices help physicians plan and offer accurate treatment to patients for their cancer treatment.

• In February 2023, The U.S. FDA granted 510(k) clearance and CE Market approval to Halcyon and Ethos radiotherapy systems advanced with HyperSight imaging solution developed by Varian Medical Systems, Inc. These devices help physicians plan and offer accurate cancer treatments to patients.

Irradiation Apparatus Market Report Scope

Global Irradiation Apparatus Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the irradiation apparatus market report on the basis of type, application and end use:

• Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Gamma Rays

  • X-rays

  • High-speed Neutrons

  • Electrons

  • Alpha-beta Particles

  • Others

• Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Diagnostic

  • Therapeutic

  • Dental

  • Others

• End Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals

  • Laboratories

  • Other End Users

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait